Cargando…

P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY

Detalles Bibliográficos
Autores principales: Leu, J., Vermeulen, A., Ling, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429329/
http://dx.doi.org/10.1097/01.HS9.0000848996.97873.30
_version_ 1784779406487584768
author Leu, J.
Vermeulen, A.
Ling, L.
author_facet Leu, J.
Vermeulen, A.
Ling, L.
author_sort Leu, J.
collection PubMed
description
format Online
Article
Text
id pubmed-9429329
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94293292022-08-31 P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY Leu, J. Vermeulen, A. Ling, L. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429329/ http://dx.doi.org/10.1097/01.HS9.0000848996.97873.30 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Leu, J.
Vermeulen, A.
Ling, L.
P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
title P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
title_full P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
title_fullStr P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
title_full_unstemmed P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
title_short P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
title_sort p1535: safety and tolerability of single escalating doses of intravenous nipocalimab in healthy japanese adults: a randomized, phase 1 placebo-controlled study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429329/
http://dx.doi.org/10.1097/01.HS9.0000848996.97873.30
work_keys_str_mv AT leuj p1535safetyandtolerabilityofsingleescalatingdosesofintravenousnipocalimabinhealthyjapaneseadultsarandomizedphase1placebocontrolledstudy
AT vermeulena p1535safetyandtolerabilityofsingleescalatingdosesofintravenousnipocalimabinhealthyjapaneseadultsarandomizedphase1placebocontrolledstudy
AT lingl p1535safetyandtolerabilityofsingleescalatingdosesofintravenousnipocalimabinhealthyjapaneseadultsarandomizedphase1placebocontrolledstudy